Press Releases

Press Releases

May 9, 2022
Establishment Labs Reports Record First Quarter 2022 Financial Results
SANTA BARBARA, Calif. --(BUSINESS WIRE)--May 9, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first
April 28, 2022
Establishment Labs to Announce First Quarter 2022 Financial Results on May 9
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Apr. 28, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the
April 26, 2022
Establishment Labs Enters Into $225 Million Credit Facility With Oaktree
- Senior secured term loan of up to $225 million , with a $150 million initial draw and $75 million available on achievement of commercial and regulatory milestones - Facility provides non-dilutive capital to fund Establishment Labs to cash flow positive under current estimates SANTA BARBARA,
April 21, 2022
Establishment Labs Notes Presentation of 2-Year Results from Motiva US IDE Study at The Aesthetic Meeting 2022
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Apr. 21, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today noted the presentation of interim study data from the augmentation
April 11, 2022
Establishment Labs Announces Participation in The Aesthetic Meeting 2022 and Sessions of Interest
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Apr. 11, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its participation in The Aesthetic Meeting 2022, which is
March 2, 2022
Establishment Labs to Present at the Cowen 42nd Annual Health Care Conference
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Mar. 2, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder
March 1, 2022
Establishment Labs Reports Fourth Quarter and Full Year 2021 Financial Results; Record Fourth Quarter Revenue of $35.3 Million
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Mar. 1, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the fourth
February 17, 2022
Establishment Labs Reaches Two Million Motiva Implants Milestone
NEW YORK --(BUSINESS WIRE)--Feb. 17, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that it has surpassed two million Motiva Implants ® in
February 15, 2022
Establishment Labs to Announce Fourth Quarter 2021 Financial Results on March 1
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Feb. 15, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the
January 10, 2022
Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
Fourth quarter revenue expected to be in the range of $35.0 million to $35.5 million , representing growth of 30% to 32% over the same period in 2020 Fiscal year 2021 revenue expected to be in the range of $126.4 million to $126.9 million , representing growth of 49% to 50% over 2020 and above the
Displaying 1 - 10 of 11